http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016008191-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91ce16ac3dbceb38cb5e6983c8c15a5a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4433
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
filingDate 2014-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c18a9bb5fc3d6bf194e42700cfaaae3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5115ce5594db6f1433c63c7d93722612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db0db60a92587bc9a52af400ed57a37d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aa8879f1971b695509791eb7c51e312
publicationDate 2016-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2016008191-A
titleOfInvention Novel pharmaceutical compound having cholesterol acyltransferase isozyme 2 (ACAT2) inhibitory activity
abstract The present invention provides a compound having an action mechanism different from that of statin drugs and having cholesterol acyltransferase isozyme 2 (ACAT2) inhibitory activity, and a pharmaceutical composition containing the compound. A compound represented by formula (I) and a pharmaceutical composition containing the compound. The medicament is useful for dyslipidemia, arteriosclerosis, hypertension, fatty liver and obesity. [R 1 is cycloalkyl, aryl, heteroaryl, etc .; n is an integer of 0-5; R 2 is halogen, cyano, nitro, alkyl, etc .; R 3 -R 5 are H, hydroxyl, alkylcarbonyloxy, etc .; R 6 Is β€”C (CH 3 ) 2 β€” or β€”CH 2 β€”] [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018508560-A
priorityDate 2014-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6916824-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011122468-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014144922-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009081957-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08291164-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010150739-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467352354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163866140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428793923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465595506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428793949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467156522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467557444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118618738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118618798

Total number of triples: 46.